Sterling Investment Counsel’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,860
| Closed | -$769K | – | 148 |
|
|
2025
Q1 | $769K | Buy |
+6,860
| New | +$769K | 0.26% | 66 |
|
|
2024
Q4 | – | Sell |
-6,842
| Closed | -$574K | – | 143 |
|
|
2024
Q3 | $574K | Buy |
6,842
+494
| +8% | +$41.4K | 0.2% | 77 |
|
|
2024
Q2 | $436K | Buy |
6,348
+1,601
| +34% | +$110K | 0.17% | 84 |
|
|
2024
Q1 | $348K | Sell |
4,747
-1,348
| -22% | -$98.7K | 0.16% | 108 |
|
|
2023
Q4 | $494K | Buy |
6,095
+534
| +10% | +$43.3K | 0.25% | 74 |
|
|
2023
Q3 | $417K | Buy |
5,561
+2,900
| +109% | +$217K | 0.24% | 79 |
|
|
2023
Q2 | $205K | Buy |
2,661
+183
| +7% | +$14.1K | 0.11% | 148 |
|
|
2023
Q1 | $206K | Sell |
2,478
-560
| -18% | -$46.5K | 0.12% | 146 |
|
|
2022
Q4 | $261K | Buy |
+3,038
| New | +$261K | 0.16% | 131 |
|